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The fine-tuning of neuronal excitability relies on a tight control of Ca2+ homeostasis.
The low voltage-activated (LVA) T-type calcium channels (Cav3.1, Cav3.2 and Cav3.3
isoforms) play a critical role in regulating these processes. Despite their wide expression
throughout the central nervous system, the implication of T-type Cav3.2 isoform in brain
functions is still poorly characterized. Here, we investigate the effect of genetic ablation
of this isoform in affective disorders, including anxiety, cognitive functions as well as
sensitivity to drugs of abuse. Using a wide range of behavioral assays we show that
genetic ablation of the cacna1h gene results in an anxiety-like phenotype, whereas
novelty-induced locomotor activity is unaffected. Deletion of the T-type channel Cav3.2
also triggers impairment of hippocampus-dependent recognition memories. Acute and
sensitized hyperlocomotion induced by d-amphetamine and cocaine are dramatically
reduced in T-type Cav3.2 deficient mice. In addition, the administration of the T-type
blocker TTA-A2 prevented the expression of locomotor sensitization observed in wildtype
mice. In conclusion, our data reveal that physiological activity of this specific Ca2+ channel
is required for affective and cognitive behaviors. Moreover, our work highlights the interest
of T-type channel blockers as therapeutic strategies to reverse drug-associated alterations.
Keywords: T-type Ca2+ channels, anxiety, memory and learning, psychostimulants, drugs of abuse, spontaneous
behavior
INTRODUCTION
Affective and cognitive functions constitute a complex ensemble
of behavioral skills strongly dependent on the fine regulation
of intracellular homeostasis and neuronal excitability. The fine
regulation of calcium (Ca2+) signaling is critical for basic neu-
ronal functions including action potential generation, neuro-
transmitter release and synaptic plasticity (Berridge, 1998). Ca2+
is the most common signal transduction element in neurons and
its entry is tightly regulated by two major classes of voltage-
gated calcium channels (VGCCs): the high-voltage activated
(HVA) (L-, P/Q and N-type) and the low-voltage activated (LVA)
(T-type) calcium channels.
Three subtypes of T-type channel have been cloned, namely,
Cav3.1 (a1G), Cav3.2 (a1H) and Cav3.3 (a1I) (Cribbs et al.,
1998, 2000; Lee et al., 1999; Zhuang et al., 2000; Gomora et al.,
2002). T-type VGCCs are widely expressed throughout the body
and, given their ability to switch neuronal firing patterns and
modulate burst-firing activity in the central nervous system they
have been implicated in several physiological aspects including
sleep regulation, body weight maintenance and pain (Huguenard,
1996; Cribbs et al., 1998, 2000; Talley et al., 1999; Nilius et al.,
2006; Bourinet et al., 2014). Disruption of calcium-dependent
low-threshold currents mediated by T-type calcium channels have
been associated with a wide range of neurological and neu-
ropsychiatric disorders including epilepsy, insomnia, Parkinson’s
disease, depression and schizophrenia as well as chronic pain
syndromes (Huguenard and Prince, 1994; Kim et al., 2001, 2003;
Anderson et al., 2005; Bourinet et al., 2005; Choi et al., 2007;
Llinas et al., 2007; Uebele et al., 2009; Miwa et al., 2011; Francois
et al., 2013; Park et al., 2013). Interestingly, several classes of
drugs currently used in therapy (antipsychotics, antidepressants
and antiepileptics) also show activity on T-type channels (Heady
et al., 2001; Santi et al., 2002; Traboulsie et al., 2006; Kraus
et al., 2007), thus suggesting T-type channels as a potential
target for some brain dysfunctions. In addition, other calcium
channel blockers including mibefradil, nicardipine, 2-octanol and
amilodipine, which non-specifically act also on T-type channels,
have been shown to reduce the psychomotor effects of cocaine,
methamphetamine and phencyclidine (PCP; Popoli et al., 1993;
Hori et al., 1998; Bisagno et al., 2010). More recently, the novel
and specific blocker of T-type channels TTA-A2 has been reported
to efficiently alleviate psychomotor effects induced by MK-801
and amphetamine as well as conditioned avoidance responding
(Kraus et al., 2010; Uslaner et al., 2012), thus strengthening the
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strategic interest of studying the T-type channels physiology and
pharmacology.
Although the implication of T-type channels in neuronal
excitability has been extensively studied (Nelson et al., 2006;
Shin et al., 2008; Iftinca and Zamponi, 2009; Cheong and Shin,
2013), very little is known about the role of T-type channels
in motor, affective and cognitive functions. Based on the fact
that Cav3.2 channels are widely expressed in the basal ganglia
circuit, in limbic as well as in cortical areas (Talley et al., 1999)
and that such circuits are critical components for the correct
computation of many of these behaviors, we therefore decided
to investigate the involvement of T-type Cav3.2 channels in
spontaneous and drugs-altered performances. Understanding the
physiological role of T-type calcium channels has been for long
time limited by the lack of selective pharmacological compounds
(Perez-Reyes, 2003), but new T-type antagonists have recently
been reported (Barrow et al., 2007; Shipe et al., 2008; Yang
et al., 2008). In this study, we deciphered the implication of
Cav3.2 calcium channel in anxiety and memory disorders as
well as in sensitivity to psychostimulants using Cav3.2 deficient
mice.
MATERIALS AND METHODS
ANIMALS
Cav3.2 knockout mice (Chen et al., 2003) were maintained in the
C57BL/6J background. Both WT and KO littermates were gene-
rated from Cav3.2 heterozygous breeders. 8–12 weeks old male
mice were used and maintained in a 12 h light/dark cycle, in stable
conditions of temperature (22◦C) and humidity (60%), with food
and water ad libitum. All experiments were in accordance with
the guidelines of the French Agriculture and Forestry Ministry for
handling animals (D34-172-13).
DRUGS
Cocaine hydrochloride (15 mg/kg, Sigma-Aldrich) and d-
amphetamine sulfate (2 mg/kg, Sigma-Aldrich) were dissolved
in 0.9% physiological saline and injected intraperitoneally (i.p.)
in a body volume of 10 ml/kg. The T-type blocker TTA-A2
(1 mg/kg, p.o., Merck) was dissolved in a solution containing
0.05% methylcellulose in H2O and 10% Tween80.
LIGHT/DARK CONFLICT TEST
The light/dark conflict test, which is believed to measure anxiety-
related behavior (Crawley and Goodwin, 1980), was performed by
placing the mouse in a cage (35 cm width× 50 cm length× 20 cm
height) that has two chambers, one bigger and bright (2/3), and
the other smaller and dark (1/3). The animal was initially placed
in the lighted side, and transitions between sides and the time
spent in each division were recorded for 10 min. The apparatus
was wiped with 70% ethanol between sessions.
OPEN FIELD
Spontaneous exploratory behavior was monitored in an open
field (white plastic arena with 35 cm width × 50 cm length ×
20 cm height) for 10 min. The open field was wiped with 70%
ethanol between sessions. The center zone was defined as a virtual
perimeter within 5 cm from the sides of the arena. Experiments
were videotaped and an observer scored the time spent in the
center (four paws inside the center zone) and the number of
transitions in the center zone.
ELEVATED-PLUS MAZE (EPM)
The elevated-plus maze (EPM) was elevated 1 m above the floor
and was constructed of black plastic with 2 open arms (5 cm width
× 35 cm length× 0.5 cm height of the walls) and two closed arms
(5 width × 35 cm length × 15 cm height of the walls). Mice were
placed in the center of an EPM facing one of the open arms and
were allowed to explore the maze for 10 min. The EPM was wiped
with 70% ethanol between sessions. Experiments were videotaped
and scored for entries and time spent in the closed arms (four
paws within closed arm) or open arms (four paws within open
arms).
ROTAROD TEST
Balance and motor coordination as well as motor learning were
assessed using a mouse accelerating rotarod (Ugo Basile, Comerio,
Italy). Mice were placed on the rotating drum that accelerated
from 4 to 40 rpm over 5 min for four trials a day, for four
consecutive days. The trial interval was 45 min for all the mice.
Rotarod scores were scored for latency to either fall or ride the
rod around.
GRIP-STRENGTH TEST
The grip-strength apparatus (BioSeb, Chaville, France) comprised
of a wire grid (8 × 8 cm) connected to an isometric force
transducer (dynamometer). Mice were lifted by the tail so that
their forepaws could grasp the grid. The mice were then gently
pulled backward by the tail until the grid was released. The mean
of three consecutive measurements for each mouse was calculated.
The muscular strength was expressed in Newton (N) as mean ±
SEM.
HORIZONTAL GRID TEST
A cage grid is held at least 35 cm above a mouse cage containing
5–7 cm of soft bedding. Each hang period begins with all four
paws of the mouse grasping the greed. The hang time is measured
from the time the grid is inverted to the time that the mouse falls
off the wire grid. A fixed limit of 60 s is applied for the hanging
period.
SPONTANEOUS AND DRUGS-INDUCED LOCOMOTOR ACTIVITY
Locomotor activity was measured as described previously (Brami-
Cherrier et al., 2005; Gangarossa et al., 2013). Horizontal and
vertical activity was measured in a circular corridor (Imetronic,
Pessac, France). Counts for horizontal activity were incremented
by consecutive interruption of two adjacent beams placed at a
height of 1 cm per 90◦ sector of the corridor (mice moving
through one-quarter of the circular corridor) and counts for ver-
tical activity (rearings) as interruption of beams placed at a height
of 7.5 cm along the corridor (mice stretching upwards). All mice
were habituated to the test apparatus, handling, and procedure
for three consecutive days before the actual experiment. In this
habituation procedure mice were placed for 30 min in the activity
box, received a first injection of saline, and were placed back in
the box for 2 h. For the acute drug injection, the handling was
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identical, except that the saline injection was replaced by adminis-
tration of cocaine (15 mg/kg, i.p.) and d-amphetamine (2 mg/kg,
i.p). In cocaine and amphetamine sensitization experiments, mice
were treated daily with cocaine (15 mg/kg, i.p.) and amphetamine
(2 mg/kg, i.p.) for five consecutive days. This repeated exposure
was followed by 8 days of withdrawal and by a challenge injection
of cocaine (15 mg/kg) or d-amphetamine (2 mg/kg). Locomotor
activity was measured as described above. The day after the
challenge, wildtype and Cav3.2 deficient mice were treated with
TTA-A2 (1 mg/kg) or its vehicle 30 min prior the administration
of d-amphetamine or cocaine. The degree of psychostimulants-
induced locomotor sensitization was determined from the slope
of the curve corresponding to the 5 days of d-amphetamine or
cocaine administration.
SPONTANEOUS ALTERNATION Y-MAZE
The Y-maze apparatus, made of Plexiglas had three identical arms
(40 × 9 × 16 cm) placed at 120◦ with respect to each other.
Each mouse was placed at the end of one arm and allowed to
explore freely the apparatus for 5 min. Spontaneous alterna-
tion performance (SAP) was assessed by scoring the pattern of
entries into each arm during the 5 min of the test. Alternations
were defined as successive entries into each of the three arms
as on overlapping triplet sets (i.e., ABC, BCA, ...). Percent of
spontaneous alternations was defined as the ratio of actual (=
total alternations) to possible (= total arm entries −2) number
of alternations × 100. Total entries were scored as an index of
ambulatory activity in the Y-maze.
NOVEL OBJECT RECOGNITION (NOR)
Mice were habituated to a V-maze with two identical arms (34
× 6 × 15 cm, at 90◦) for 10 min. The following day, mice
were allowed to freely explore two objects (A and B) located
at the end of the two arms. Object interaction was defined as
approaching the object with the nose closer than 1 cm. Following
a retention interval of 24 h, mice underwent a 5 min recall session
during which the V-maze contained a familiar object (A) and
a novel object (C). Following each session, the objects and the
open field were cleaned with 70% ethanol. The experiments were
videotaped and the time spent exploring the objects was scored.
The percentage of exploration was calculated using the formula %
exploration = ((Time C)/(Time A + Time C))× 100.
SPATIAL OBJECT RECOGNITION (SOR)
Mice were habituated to an arena for 10 min. The following
day, mice were allowed to freely explore two different objects (A
and B) located in the same site of the arena. Object interaction
was defined as approaching the object with the nose closer than
1 cm. Following a retention interval of 24 h, mice underwent
a 5 min recall session during which the arena contained one of
the two objects displaced in the other site of the arena (novel
place). Following each session, the objects and the open field were
cleaned with 70% ethanol. The experiments were videotaped and
the time spent exploring the objects was scored. The percentage
of exploration was calculated using the formula % exploration =
((Time B)/(Time A + Time B))× 100.
MARBLE BURYING
Mice were placed in the center of a clear plastic cage containing
5 cm of sawdust bedding with 24 glass marbles (1.5 cm diameter)
on top, arranged in four rows of six marbles. The lid of the cage
was used to prevent mice from escaping. Mice were then allowed
to explore the testing chamber for 20 min. The number of marbles
buried at least two-thirds deep were counted.
STATISTICS
The data were analyzed using one-way or two-way ANOVA
followed by Bonferroni post-hoc test for specific comparisons.
Student’s t-test with equal variances was used for groups of two,
when relevant. In all cases, significance threshold was set at p <
0.05. Statistical analyses were performed using GraphPad Prism
5.0 (GraphPad Prism Software Inc., San Diego, USA).
RESULTS
NOVELTY-INDUCED SPONTANEOUS LOCOMOTOR ACTIVITY IS NOT
IMPAIRED IN Cav3.2 DEFICIENT MICE
We first investigated the spontaneous locomotor activity of Cav3.2
deficient mice in response to novelty, in a non-stressful environ-
ment (low luminosity). No differences in the initial horizontal
activity or in the habituation phase (3 days) were observed
between WT and Cav3.2 KO mice (Figures 1A–C), thus sug-
gesting intact exploratory drive. In addition, despite a mild but
significant attenuation in vertical locomotor activity (rearing
behavior) observed in Cav3.2 deficient mice during the first day
(Figures 1D and E), both genotypes showed habituation to the
testing environment (Figure 1F).
To investigate whether the genetic ablation of Cacna1h gene
might induce muscular alteration that can ultimately impact on
the spontaneous behavior of mice, we assessed muscular strength
using two essays: the grip-strength and the grid test. Both tests
revealed no major differences between genotypes. Grip-strength
test: WT (1.68 N ± 0.076, n = 15) and KO (1.85 N ± 0.084, n =
14). Grid test: WT (59.87 sec± 0.13, n = 15) and KO (59.79 sec±
0.15, n = 14).
Taken together our results show that Cacna1h gene dele-
tion does not alter spontaneous locomotor performance and
exploratory drive.
Cav3.2 DEFICIENT MICE SHOW ELEVATED ANXIETY
Because of the reduced vertical locomotor activity, we next
investigated anxiety-related behaviors in Cav3.2 deficient mice
using well-established behavioral paradigms: the light/dark con-
flict context, the EPM and the open field tests. In the light/dark
test, KO mice spent less time in the light compartment and
more time in the dark compartment compared to WT mice
(Figure 2A). Cav3.2 deficient mice were also slightly less active
than WT as demonstrated by the reduced number of entries in
both compartments (light and dark) (Figure 2B). In the EPM test,
Cav3.2 deficient mice spent less time in the open arms compared
to their WT littermates confirming an increased anxiety-related
phenotype (Figure 2C). No differences were observed in the
number of entries in both closed and open arms suggesting that
this effect is not the result of an altered locomotor response
(Figure 2D). To further extend these behavioral observations, we
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FIGURE 1 | Spontaneous locomotor activity in Cav3.2 deficient mice. (A)
Horizontal locomotor activity of Cav3.2 null mice (n = 22) and their WT
littermates (n = 26) in a novel non-stressful environment. Data (means ±
SEM) were analyzed using two-way ANOVA: (Time × Genotype: F (14,644) =
1.607, P = 0.0724; Time: F (14,644) = 157.8, P < 0.0001; Genotype: F (1,46) =
0.0268, P = 0.8707). (B) Cumulative locomotor activity of WT and Cav3.2 KO
mice over a 150 min period. Data (means ± SEM) were analyzed using
Student’s t-test: NS. (C) Environmental habituation over a period of 3 days
measured as a reduction of spontaneous horizontal locomotor activity. Data
(means ± SEM) were analyzed using two-way ANOVA: (Time × Genotype:
F (2,92) = 0.8412, P = 0.4345; Time: F (2,92) = 161.4, P < 0.0001; Genotype:
F (1,46) = 0.9561, P = 0.3333). Specific comparisons: *** p < 0.001 (WT-Day3
vs. WT-Day1) and ◦◦◦ p < 0.001 (KO-Day3 vs. KO-Day1). (D) Rearing activity
(vertical locomotor activity) of Cav3.2 null mice (n = 22) and their WT
littermates (n = 26) in a novel non-stressful environment. Data (means ±
SEM) were analyzed using two-way ANOVA: (Time × Genotype: F (14,644) =
3.751, P < 0.0001; Time: F (14,644) = 70.86, P < 0.0001; Genotype: F (1,46) =
4.601, P = 0.0373). Specific comparisons: ** p < 0.01 and * p < 0.05 (KO vs.
WT). (E) Cumulative rearing activity of WT and Cav3.2 KO mice over a 150
min period. Data (means ± SEM) were analyzed using Student’s t-test: * p <
0.05. (F) Environmental habituation over a period of 3 days measured as a
reduction of spontaneous rearing activity. Data (means ± SEM) were
analyzed using two-way ANOVA: (Time × Genotype: F (2,92) = 1.139, P =
0.3246; Time: F (2,92) = 76.78, P < 0.0001; Genotype: F (1,46) = 3.874, P =
0.05). Specific comparisons: *** p < 0.001 (WT-Day3 vs. WT-Day1), ◦◦◦ p <
0.001 (KO-Day3 vs. KO-Day1) and # p < 0.05 (KO-Day1 vs. WT-Day1).
measured the spontaneous behavior of Cav3.2 deficient mice to
explore a novel and stressful environment using the open field
test. As shown in Figure 2E, Cav3.2 deficient mice spent less time
in the center of the arena compared to their WT littermates and
made an equal number of transitions in the center zone compared
to WT mice therefore indicating increased anxiety rather than a
general locomotor deficit (Figure 2F).
Anxiety disorders are often exacerbated by repetitive and
compulsive behaviors, such as in obsessive-compulsive disorder
(OCD), in which abnormal repetitive behaviors can take place to
alleviate recurrent and generalized anxiety. The marble burying
test was then performed to assess whether Cav3.2 null mice dis-
played some forms of compulsivity. No differences were observed
in the number of marbles buried: WT (15.15 ± 1.5, n = 13) and
KO (16.31± 0.5, n = 13).
Altogether these data strongly suggest that T-type Cav3.2
channel influence anxiety-related behaviors, which do not seem
being associated with repetitive and compulsive behaviors. Fur-
ther studies should be performed to investigate whether T-type
channels participate to altered behaviors observed in OCD.
RECOGNITION MEMORY FUNCTIONS ARE DISRUPTED Cav3.2 NULL
MICE
Previous studies have shown that T-type Cav3.2 is critical for
hippocampal LTP, cued-context fear conditioning and passive
avoidance tasks (Chen et al., 2012). We then investigated two
hippocampal recognition memory tasks, the novel and the spatial
object recognition (NOR and SOR, respectively). As shown in
Figures 3A, B, Cav3.2 deficient mice do not show preference for
the novel or the relocated object during the recall session 24 h
later as opposed to the WT. This altered response is not the result
of an impairment of the exploratory drive since the exploration of
the two objects is not significantly different from the WT animal
during the familiarization phase (data not shown). Interestingly,
the spatial working memory, assessed using the spontaneous
alternation in the Y-Maze, was unaffected in Cav3.2 deficient mice
(Figure 3C).
Motor skill learning was also investigated in Cav3.2 defi-
cient mice using the accelerating rotarod. No differences
were observed during the first day of rotarod training, thus
suggesting unaltered motor coordination in Cav3.2 deficient
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FIGURE 2 | Anxiety-like behavior in Cav3.2 deficient mice. Mice were
tested in three anxiety-related behavioral paradigms: the ligh/dark conflict
test, the elevated plus maze test (EPM) and the open field test. (A)
Histograms show the percentage of time Cav3.2 KO (n = 14) and WT mice
(n = 15) spent in the light and the dark compartments. (B) Histograms
indicate the number of entries of Cav3.2 KO (n = 14) and WT mice (n = 15)
in the light and the dark compartments. (A and B) Data (means ± SEM)
were analyzed using Student’s t-test: * p < 0.05; ** p < 0.01. (C)
Histograms show the percentage of time Cav3.2 KO (n = 17) and WT mice
(n = 19) spent in the open arms of the EPM. Data (means ± SEM) were
analyzed using Student’s t-test: * p < 0.05. (D) Histograms indicate the
number of entries of Cav3.2 KO (n = 17) and WT mice (n = 19) in open and
closed arms of EPM. Data (means ± SEM) were analyzed using student’s
t-test: ns. (E) Histograms show the percentage of time Cav3.2 KO (n = 14)
and WT mice (n = 15) spent in the center zone of the open field. Data
(means ± SEM) were analyzed using student’s t-test: * p < 0.05. (F)
Histograms indicate the number of transitions Cav3.2 KO (n = 14) and WT
mice (n = 15) made in the center zone of the open field. Data (means ±
SEM) were analyzed using student’s t-test: ns.
mice (Figures 3D, E). Although Cav3.2 KO mice showed
a significant reduction of the motor performance compared
to their WT littermates (Figures 3D, E), both genotypes
gradually acquired motor skills following extensive training
(Figures 3D, E).
Altogether, these data strongly suggest that T-type Cav3.2
channels influence preferentially memory recognition tasks, but
spare working memory and motor learning.
PSYCHOMOTOR EFFECTS OF D-AMPHETAMINE AND COCAINE ARE
REDUCED IN Cav3.2 DEFICIENT MICE
The psychomotor effects of cocaine, methamphetamine and PCP
have been shown to partly involve the activity of T-type calcium
channels (Popoli et al., 1993; Hori et al., 1998; Bisagno et al.,
2010). To test the specific contribution of T-type Cav3.2 channels
in these locomotor responses, the acute hyperlocomotion induced
by d-amphetamine (2 mg/kg, i.p.) and cocaine (15 mg/kg, i.p.)
was evaluated in WT and Cav3.2 deficient mice. As shown in
Figure 4A, the total locomotor activity over a 120 min period
induced by a single injection of d-amphetamine was dramatically
reduced in Cav3.2 deficient mice compared to their WT litter-
mates. A similar effect was also observed when mice were treated
with cocaine (Figure 4B).
We next determine whether Cav3.2 KO mice could still
undergo locomotor sensitization despite the reduced acute loco-
motor response. Repeated exposure to d-amphetamine (2 mg/kg)
results in a progressive and persistent enhancement of the loco-
motor response in WT mice (Figure 4C). Cav3.2 deficient mice
also displayed locomotor sensitization but this response remained
lower than in WT mice even when the mice were challenged
after a withdrawal period of 8 days (Figure 4C). Interestingly,
taking into account the slope sensitization, the locomotor sensiti-
zation to d-amphetamine was less pronounced in Cav3.2 deficient
mice than in their WT controls (Figure 4D). Similar results
have been obtained when mice were repeatedly injected with
cocaine (Figures 4E, F). Altogether, these results show that Cav3.2
null mice displayed a reduction of sensitized responses to d-
amphetamine and cocaine.
Finally, we examined whether a pharmacological acute block-
ade of T-type Ca2+ channel could affect the expression of loco-
motor sensitization in WT animals and therefore recapitulate
the phenotype of Cav3.2 null mice. To test this possibility, WT
mice sensitized to d-amphetamine (Figures 5A–B) or cocaine
(Figures 5D–E) were challenged with either vehicle or TTA-
A2 (1 mg/kg, p.o.), a specific but non-selective T-type blocker
prior to the last psychostimulant treatment (day 14). TTA-A2
blocked the expression of d-amphetamine and cocaine locomotor
sensitization (Figures 5A, B, D, E). When the identical treatment
regimen was performed in sensitized Cav3.2 deficient mice, TTA-
A2 had no effect on the expression of either d-amphetamine
or cocaine locomotor sensitization (Figures 5A, C, D, F). Taken
together, these results suggest that the effect of this T-type Ca2+
channel blocker on the expression of sensitization observed in WT
mice was most likely attributable to the specific inhibition of the
Cav3.2 isoform.
DISCUSSION
In the present study, we evaluate the effect of genetic ablation
of the Cacna1h gene in several behavioral paradigms related to
motor, affective and cognitive functions. T-type calcium channels
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FIGURE 3 | Memory functions in Cav3.2 deficient mice. (A) Graph shows
the percentage of exploration time of Cav3.2 KO (n = 14) and WT (n = 15)
mice in the NOR test. Data (means ± SEM) were analyzed using two-way
ANOVA: (Object exploration × Genotype: F (1,44) = 25.80, P < 0.0001;
Object exploration: F (1,44) = 37.58, P < 0.0001; Genotype: F (1,44) =
3.245e-014, P = 0.99). Specific comparisons: *** p < 0.001 (WT-new vs.
WT-familiar). (B) Graph shows the percentage of exploration time of Cav3.2
KO (n = 14) and WT (n = 15) mice in the SOR test. Data (means ± SEM)
were analyzed using two-way ANOVA: (Object exploration × Genotype:
F (1,44) = 31.80, P < 0.0001; Object exploration: F (1,44) = 48.81, P < 0.0001;
Genotype: F (1,44) = 1.324e-013, P = 0.99). Specific comparisons: *** p <
0.001 (WT-new vs. WT-familiar). (C) Histogram indicates the percentage of
spontaneous alternation of Cav3.2 KO (n = 14) and WT (n = 15) in the
Y-maze test. The red dotted line represents the chance level of alternation
(random, 50%). Data (means ± SEM) were analyzed using Student’s t-test:
ns. (D) Curves show coordination and motor learning in WT (n = 22) and
Cav3.2 KO (n = 22) mice over a training period of 4 days. Data (means ±
SEM) were analyzed using two-way ANOVA (Time × Genotype: F (3,168) =
2.017, P = 0.1134; Time: F (3,168) = 19.03, P < 0.0001; Genotype: F (1,168) =
20.12, P < 0.0001). Specific comparisons: ** p < 0.01 (KO-Day4 vs.
WT-Day4). (E) Percentage of motor learning in WT (n = 22) and Cav3.2 KO
(n = 22). Data (means ± SEM) were analyzed using two-way ANOVA (Time
× Genotype: F (1,84) = 5.643, P < 0.05; Time: F (1,84) = 5.654, P < 0.05;
Genotype: F (1,84) = 49.11, P < 0.0001). Specific comparisons: *** p <
0.001 (WT-Day4 vs. WT-Day1), ** p < 0.01 (KO-Day4 vs. KO-Day1) and
◦◦ p < 0.01 (KO-Day4 vs. WT-Day4).
mediate calcium-dependent low-threshold currents and they are
associated with rhythmic burst-firing activities of some brain
regions (Beurrier et al., 1999; Park et al., 2010; Tai et al., 2011;
Bourinet et al., 2014). By regulating Ca2+ homeostasis and neu-
ronal activation, T-type calcium channels (Cav3.1, Cav3.2 and
Cav3.3) represent an interesting and promising pharmacological
target. T-type calcium channels are widely expressed in the brain
(Talley et al., 1999) and the T-type Cav3.2 isoform is found in key
regions involved in affective and cognitive behaviors. However,
due to the lack of selective compounds for each T-type isoforms,
little is known about their respective specific implications in the
above-mentioned functions. Here, we focused on studying the T-
type Cav3.2 channel using Cav3.2 deficient mice. Our findings
reveal that the lack of Cacna1h gene promotes anxiety-related
behavior, impairs learning and memory formation and results in
a reduced sensitivity to psychostimulants (d-amphetamine and
cocaine).
The involvement of T-type calcium channels in anxiety-related
disorders is poorly documented. Our study reveals that mice
lacking the T-type Cav3.2 showed elevated anxiety across a range
of behavioral tests including the light/dark conflict test, the EPM
and the open field. These phenotypes were not the result of a gen-
eral motor impairment since Cav3.2 deficient showed unaltered
locomotor response when placed in a novel environment (see also
Choi et al., 2007). However, our results contrast with this previous
study reporting a lack of anxiety-related phenotype in Cav3.2 KO
mice in the light/dark conflict test (Choi et al., 2007). Different
parameters could explain this apparent discrepancy. First, the
genetic background of the Cav3.2 deficient mice employed in
both studies was different. While our mice were on a C57BL/6J
background the previous study used mice on a mixed 129/sv
and C57BL/6J background (Choi et al., 2007). C57BL/6 and 129
mouse lines are the most commonly used background strains in
research. However, these two strains show markedly differences in
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FIGURE 4 | Psychomotor effects of d-amphetamine and cocaine in Cav3.2
deficient mice. (A) Locomotor activity induced by single administration of
d-amphetamine (2 mg/kg, i.p.) in WT (n = 17) and Cav3.2 KO (n = 15) mice.
Data (means ± SEM) were analyzed using two-way ANOVA: (Treatment ×
Genotype: F (14,420) = 4.805, P < 0.0001; Treatment: F (14,420) = 8.34, P <
0.0001; Genotype: F (1,30) = 15.85, P < 0.001). (B) Locomotor activity induced
by single administration of cocaine (15 mg/kg, i.p.) in WT (n = 9) and Cav3.2
KO (n = 7) mice. Data (means ± SEM) were analyzed using two-way ANOVA:
(Treatment × Genotype: F (14,196) = 12.09, P < 0.0001; Treatment: F (14,196) =
17.53, P < 0.0001; Genotype: F (1,14) = 20.92, P < 0.001). (C) Locomotor
activity induced by repeated administration (sensitization protocol) of
d-amphetamine (2 mg/kg, i.p.) in WT (n = 17) and Cav3.2 KO (n = 15). Data
(means ± SEM) were analyzed using two-way ANOVA: (Treatment ×
Genotype: F (6,210) = 5.280, P < 0.001; Treatment: F (6,210) = 43.34, P <
0.0001; Genotype: F (1,210) = 147.3, P < 0.001). Specific comparisons: *** p <
0.001 (KO vs. WT), ◦◦◦ p < 0.001 (WT-Day5 vs. WT-Day1) and ## p < 0.01
(KO-Day5 vs. KO-Day1). (D) Degree of d-amphetamine-induced sensitization
measured as a slope of sensitization curves in WT (n = 17) and Cav3.2 KO (n
= 15). Data (means ± SEM) were analyzed using Student’s t-test: * p < 0.05.
(E) Locomotor activity induced by repeated administration (sensitization
protocol) of cocaine (15 mg/kg, i.p.) in WT (n = 9) and Cav3.2 KO (n = 7). Data
(means ± SEM) were analyzed using two-way ANOVA: (Treatment ×
Genotype: F (6,98) = 9.086, P < 0.0001; Treatment: F (6,98) = 37.96, P < 0.0001;
Genotype: F (1,98) = 301.3, P < 0.0001). Specific comparisons: *** p < 0.001
(KO vs. WT), ◦◦◦ p < 0.001 (WT-Day5 vs. WT-Day1) and # p < 0.05 (KO-Day5
vs. KO-Day1). (F) Degree of cocaine-induced sensitization measured as a
slope of sensitization curves in WT (n = 9) and Cav3.2 KO (n = 7). Data
(means ± SEM) were analyzed using student’s t-test: * p < 0.05.
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FIGURE 5 | Effect of the T-type calcium channel inhibitor TTA-A2 on
psychostimulants-induced locomotor activity. (A) Histograms show the
effect of TTA-A2 (1 mg/kg, p.o.) on d-amphetamine-sensitized mice. Data
(means ± SEM) were analyzed using two-way ANOVA: A (Treatment ×
Genotype: F (1,28) = 26.47, P < 0.0001; Treatment: F (1,28) = 2.595, P =
0.1185; Genotype: F (1,28) = 53.99, P < 0.0001). Specific comparisons:
*** p < 0.001 (WT-TTA-A2+d-amph vs. WT-Veh+d-amph) and ◦◦◦ p < 0.001
(KO-Veh+d-amph vs. WT-Veh+d-amph). (B and C) Curves showing the
behavioral profile of T-type channels blocker TTA-A2 in WT (B, n = 9) and
Cav3.2 KO (C, n = 7) d-amphetamine-treated mice. Data (means ± SEM)
were analyzed using two-way ANOVA: B (Treatment × Time: F (14,224) =
9.302, P < 0.0001; Time: F (14,224) = 34.60, P < 0.0001; Treatment: F (1,16) =
83.58, P < 0.0001); C (Treatment × Time: F (14,168) = 2.717, P < 0.01; Time:
F (14,168) = 85.72, P < 0.0001; Treatment: F (1,12) = 2.108, P = 0.1722). (D)
Histograms show the effect of TTA-A2 (1 mg/kg, p.o.) on cocaine-sensitized
mice. Data (means ± SEM) were analyzed using two-way ANOVA: A
(Treatment × Genotype: F (1,28) = 24.15, P < 0.0001; Treatment: F (1,28) =
27.96, P < 0.0001; Genotype: F (1,28) = 34.54, P < 0.0001). Specific
comparisons: *** p < 0.001 (WT-TTA-A2+Coc vs. WT-Veh+Coc) and ◦◦◦ p <
0.001 (KO-Veh+Coc vs. WT-Veh+Coc). (E and F) Curves showing the
behavioral profile of T-type calcium channels blocker TTA-A2 in WT (E, n = 9)
and Cav3.2 KO (F, n = 7) cocaine-treated mice. Data (means ± SEM) were
analyzed using two-way ANOVA: E (Treatment × Time: F (14,224) = 2.31, P <
0.01; Time: F (14,224) = 37.34, P < 0.0001; Treatment: F (1,16) = 50.35, P <
0.0001); F (Treatment × Time: F (14,168) = 1.768, P < 0.05; Time: F (14,168) =
29.27, P < 0.0001; Treatment: F (1,12) = 0.8157, P = 0.3842).
learning and memory, anxiety and sensitivity to drugs (Homanics
et al., 1999; Contet et al., 2001; Cook et al., 2001, 2002; Murphy
et al., 2001; Bouwknecht and Paylor, 2002). It is worth to men-
tion that, in the light/dark conflict test, C57BL/6 show higher
transition frequency and reduced time in the dark compartment
compared to the 129 mouse line (Bouwknecht and Paylor, 2002).
The second aspect is related to the behavioral procedure used to
perform the light/dark conflict test. In the present study, mice
were always placed in the light compartment at the beginning of
the session (Crawley and Goodwin, 1980; Gao and Cutler, 1992;
Bourin and Hascoët, 2003). This contrasts with the study of Choi
and colleagues and could explain why different results have been
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observed between the two studies (Choi et al., 2007). Further-
more, the behavioral responses we observed in the EPM and the
open field test strongly support an implication of Cav3.2 T-type
calcium channels in anxiety-related behaviors. Even though our
results suggest that the anxious phenotype observed in KO mice
is not associated with repetitive behavior, a study clearly aiming
at deciphering the role of T-type calcium channels in OCD-like
behavior need to be undertaken.
Calcium-dependent signaling is important for LTP and
learning and memory functions. NMDA-independent influx of
Ca2+ through VGCCs has been shown to be crucial for both
hippocampus- and amygdala-dependent tasks. Thus, HVA L-type
Cav1.2 and Cav1.3 mutant mice showed altered spatial memory
and impaired consolidation of fear conditioning, respectively
(Moosmang et al., 2005; McKinney and Murphy, 2006; White
et al., 2008). In addition, ablation of HVA P/Q-type Ca2+ chan-
nels impaired memory functions (Mallmann et al., 2013). Inter-
estingly, disruption of the T-type calcium channel activity has
been reported to strongly alter physiological induction and main-
tenance of LTP in the hippocampus, visual cortex and cerebellum
(Yoshimura et al., 2008; Chen et al., 2012; Ly et al., 2013) and
mutations of the human cacna1h gene have been associated with
autism spectrum disorder (ASD; Splawski et al., 2006). Moreover,
the demonstration that T-type calcium channels are interacting
with the neurotransmitter release machinery reinforces the notion
of their impact on synaptic transmission (Tang et al., 2011; Weiss
et al., 2012a,b). Our study further highlights the emerging role of
Cav3.2 channels in learning and memory functions. Thus, while
the working memory function is spared, memory recognition
assessed by using the NOR and SOR is strongly impaired in Cav3.2
deficient mice. This impairment is not the result of a deficit of
exploratory drive since Cav3.2 null mice and WT animals showed
similar object exploration during the familiarization phases of the
two behavioral tasks. In contrast, in the Morris water maze, mem-
ory formation and retrieval are not altered in Cav3.2 deficient
mice (Chen et al., 2012). In addition, we also found that, although
less efficient, Cav3.2 null mice were able to acquired motor skills
suggesting the neural systems involved in these processes are
functional. Altogether these functional data strongly suggest that
T-type Cav3.2 channels influence a subset of specific learning and
memory processes.
The contribution of VGCCs in the action of psychostimu-
lant drugs has been extensively documented (Karler et al., 1991;
Ansah et al., 1993; Schechter, 1993; Pierce and Kalivas, 1997;
Pierce et al., 1998; Licata et al., 2000; Newton et al., 2004, 2008;
Rajadhyaksha and Kosofsky, 2005; Chartoff et al., 2006; Bisagno
et al., 2010; Giordano et al., 2010). However, little is known about
the contribution of T-type calcium channels. Here, we found
that T-type Cav3.2 channels are necessary for acute psychomotor
effects induced by cocaine and d-amphetamine. These data extend
previous results obtained in rats showing that the pharmacologi-
cal blockade of T-type calcium channels achieved with TTA-A2,
strongly reduced d-amphetamine-induced psychomotor effects
(Bisagno et al., 2010; Uslaner et al., 2012). Interestingly, this initial
study suggested that this effect would result from an alteration of
the glutamatergic transmission since TTA-A2 inhibits glutamate
release in the nucleus accumbens leaving unaltered dopamine
influx (Uslaner et al., 2012). However, functional coupling of T-
type currents to calcium-activated-potassium channels has been
proposed to modify firing pattern of midbrain DA neurons
(Wolfart and Roeper, 2002), a mechanism that may contribute to
reward-based processes.
Our study also highlights that T-type Cav3.2 channels par-
ticipate to psychostimulant-induced development and expression
of drug sensitization. Interestingly, previous studies pointed out
that Cav1.3 L-type calcium channels (LTCCs) mediate develop-
ment of sensitization whereas Cav1.2 LTCCs mediate expression
of the psychostimulant-induced sensitized response (Giordano
et al., 2010). Furthermore, our pharmacological experiment,
using TTA-A2, strongly suggests that the Cav3.2 channel is the
only member of the T-type family required for the expression
of sensitization, a crucial finding for future relevance in clinical
treatments of addictions. Given the high expression of Cav3.2
mRNA in the striatum, the nucleus accumbens and other nuclei
that composed the rewarding systems (Talley et al., 1999), it is
tempting to speculate that the effects observed are associated with
altered functions of this T-type isoform within the circuit. Future
experiments are necessary to identify whether the altered acute
responses are associated with the function of the Cav3.2 channel
in a particular cell-type of the system mentioned above.
Follow up explorations would be needed in the next future
to precise the cellular basis of the underlying circuits involved,
especially when cell and tissue specific conditional knockout
mice will be available. Moreover, elucidation of the cellular and
subcellular Cav3.2 expression patterns is still pending to the avail-
ability of faithful antibodies. We should also mention that brain
regions (i.e., cortex, hippocampus, striatum, midbrain) known to
be important for the behaviors here explored express high level
of Cav3.2 transcripts (Talley et al., 1999), and that functional
presence of Cav3.2 like T-type currents is well established in these
regions (Perez-Reyes, 2003).
Our study shows that T-type Cav3.2 calcium channels are
strongly involved in affective and cognitive functions. In depth
behavioral characterization of Cav3.2 deficient mice revealed an
anxiety-like phenotype although general exploratory drive was
unaltered. We further demonstrate an impairment of recognition
memory functions but intact working memory processing in
Cav3.2-ablated mice. In addition, we also provide evidence for an
involvement of specific T-type Cav3.2 calcium channels in sensiti-
zation processes triggered by commonly abused psychostimulant
drugs.
However, it should be mentioned that mechanisms of func-
tional compensations by other T-type calcium channels might
occur due to global knockout of Cav3.2 although no compensa-
tion in Cav3.1 and Cav3.3 has been detected at the level of the
hippocampus (see GEO1).
In conclusion, our data highlight that physiological activity
of the specific T-type Cav3.2 calcium channel is required for
affective and cognitive behaviors suggesting potential functional
implications of this calcium channel in many brain disorders.
The emergence of T-type selective pharmacology is therefore very
promising and holds many clinical perspectives.
1www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE30846
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